N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide

C108H165N21O21 — CID 54484532

IUPACN-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide
SMILESCCN(CC)CCNC(=O)CCCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O.COc1cc(C(=O)NCCCCCCCCCCCn2c(=O)c3c(ncn3C)n(C)c2=O)cc(OC)c1OC.COc1cc(CCNC(=O)CCCCCCCCCCn2c(=O)c3c(ncn3C)n(C)c2=O)cc(OC)c1OC.COc1cc(CNC(=O)CCCCCCCCCn2c(=O)c3c(ncn3C)n(C)c2=O)cc(OC)c1OC
InChIInChI=1S/C29H43N5O6.C28H41N5O6.C27H39N5O6.C24H42N6O3/c1-32-20-31-27-25(32)28(36)34(29(37)33(27)2)17-13-11-9-7-6-8-10-12-14-24(35)30-16-15-21-18-22(38-3)26(40-5)23(19-21)39-4;1-31-19-30-25-23(31)27(35)33(28(36)32(25)2)16-14-12-10-8-6-7-9-11-13-15-29-26(34)20-17-21(37-3)24(39-5)22(18-20)38-4;1-30-18-29-25-23(30)26(34)32(27(35)31(25)2)14-12-10-8-6-7-9-11-13-22(33)28-17-19-15-20(36-3)24(38-5)21(16-19)37-4;1-5-29(6-2)18-16-25-20(31)15-13-11-9-7-8-10-12-14-17-30-23(32)21-22(26-19-27(21)3)28(4)24(30)33/h18-20H,6-17H2,1-5H3,(H,30,35);17-19H,6-16H2,1-5H3,(H,29,34);15-16,18H,6-14,17H2,1-5H3,(H,28,33);19H,5-18H2,1-4H3,(H,25,31)
InChIKeyXRJJEUMIOQXUTQ-UHFFFAOYSA-N
MW2093.63 g/mol
LogP12.03
Rot. Bonds64

About N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide

N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide (PubChem CID 54484532) has the molecular formula C108H165N21O21 and a molecular weight of 2093.63 g/mol. Its IUPAC name is N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide.

Molecular Properties

Compound NameN-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide
PubChem CID54484532
Molecular FormulaC108H165N21O21
Molecular Weight2093.63 g/mol
Exact Mass2092.25
IUPAC NameN-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide
SMILESCCN(CC)CCNC(=O)CCCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O.COc1cc(C(=O)NCCCCCCCCCCCn2c(=O)c3c(ncn3C)n(C)c2=O)cc(OC)c1OC.COc1cc(CCNC(=O)CCCCCCCCCCn2c(=O)c3c(ncn3C)n(C)c2=O)cc(OC)c1OC.COc1cc(CNC(=O)CCCCCCCCCn2c(=O)c3c(ncn3C)n(C)c2=O)cc(OC)c1OC
InChIInChI=1S/C29H43N5O6.C28H41N5O6.C27H39N5O6.C24H42N6O3/c1-32-20-31-27-25(32)28(36)34(29(37)33(27)2)17-13-11-9-7-6-8-10-12-14-24(35)30-16-15-21-18-22(38-3)26(40-5)23(19-21)39-4;1-31-19-30-25-23(31)27(35)33(28(36)32(25)2)16-14-12-10-8-6-7-9-11-13-15-29-26(34)20-17-21(37-3)24(39-5)22(18-20)38-4;1-30-18-29-25-23(30)26(34)32(27(35)31(25)2)14-12-10-8-6-7-9-11-13-22(33)28-17-19-15-20(36-3)24(38-5)21(16-19)37-4;1-5-29(6-2)18-16-25-20(31)15-13-11-9-7-8-10-12-14-17-30-23(32)21-22(26-19-27(21)3)28(4)24(30)33/h18-20H,6-17H2,1-5H3,(H,30,35);17-19H,6-16H2,1-5H3,(H,29,34);15-16,18H,6-14,17H2,1-5H3,(H,28,33);19H,5-18H2,1-4H3,(H,25,31)
InChIKeyXRJJEUMIOQXUTQ-UHFFFAOYSA-N
XLogP12.03
TPSA449.99 Ų
H-Bond Donors4
H-Bond Acceptors38
Rotatable Bonds64
Heavy Atoms150
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002093.63
LogP ≤ 512.03
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1038

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide?
The IUPAC name of N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide (CID 54484532) is N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide.
What is the SMILES notation for N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide?
The canonical SMILES for N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide is CCN(CC)CCNC(=O)CCCCCCCCCCn1c(=O)c2c(ncn2C)n(C)c1=O.COc1cc(C(=O)NCCCCCCCCCCCn2c(=O)c3c(ncn3C)n(C)c2=O)cc(OC)c1OC.COc1cc(CCNC(=O)CCCCCCCCCCn2c(=O)c3c(ncn3C)n(C)c2=O)cc(OC)c1OC.COc1cc(CNC(=O)CCCCCCCCCn2c(=O)c3c(ncn3C)n(C)c2=O)cc(OC)c1OC.
What is the InChIKey of N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide?
The InChIKey is XRJJEUMIOQXUTQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H43N5O6.C28H41N5O6.C27H39N5O6.C24H42N6O3/c1-32-20-31-27-25(32)28(36)34(29(37)33(27)2)17-13-11-9-7-6-8-10-12-14-24(35)30-16-15-21-18-22(38-3)26(40-5)23(19-21)39-4;1-31-19-30-25-23(31)27(35)33(28(36)32(25)2)16-14-12-10-8-6-7-9-11-13-15-29-26(34)20-17-21(37-3)24(39-5)22(18-20)38-4;1-30-18-29-25-23(30)26(34)32(27(35)31(25)2)14-12-10-8-6-7-9-11-13-22(33)28-17-19-15-20(36-3)24(38-5)21(16-19)37-4;1-5-29(6-2)18-16-25-20(31)15-13-11-9-7-8-10-12-14-17-30-23(32)21-22(26-19-27(21)3)28(4)24(30)33/h18-20H,6-17H2,1-5H3,(H,30,35);17-19H,6-16H2,1-5H3,(H,29,34);15-16,18H,6-14,17H2,1-5H3,(H,28,33);19H,5-18H2,1-4H3,(H,25,31).
What are the key properties of N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide?
N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide has a molecular weight of 2093.63 g/mol, XLogP of 12.03, 64 rotatable bonds, 4 hydrogen bond donors, and 38 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(diethylamino)ethyl]-11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecanamide;11-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[2-(3,4,5-trimethoxyphenyl)ethyl]undecanamide;10-(3,7-dimethyl-2,6-dioxopurin-1-yl)-N-[(3,4,5-trimethoxyphenyl)methyl]decanamide;N-[11-(3,7-dimethyl-2,6-dioxopurin-1-yl)undecyl]-3,4,5-trimethoxybenzamide is sourced from PubChem (CID 54484532), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).